查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1499393

基於電動車的液態切片市場：按類型、應用和最終用戶分類 - 2024-2030 年全球預測

EV-Based Liquid Biopsy Market by Type (Assay Kits, Instruments, Services), Application (Early Cancer Screening, Recurrence Monitoring, Therapy Selection), End User - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2023年基於EV的液態切片市場規模為4.0​​966億美元，預計2024年將達到4.7312億美元，2030年將達到11.508億美元，複合年成長率為15.89%。

基於 EV 的液態切片包括從體液中提取和分析細胞外囊泡 (EV)，代表了非侵入性癌症診斷和監測的開拓前緣。 EV是細胞釋放的脂質結合顆粒，含有豐富的分子訊息，如DNA、RNA和蛋白質，反映了其來源細胞的健康狀況。推動基於 EV 的液態切片的關鍵因素包括其非侵入性、早期癌症檢測的潛力、監測疾病進展和治療反應的能力以及提供腫瘤異質性洞察的能力。然而，這項新興技術面臨挑戰，例如需要標準化的 EV 分離和分析方法、檢測低豐度 EV 的靈敏度以及解釋所獲得的資料的複雜性。解決這些限制需要進行嚴格的研究來建立統一的通訊協定，進步分析技術以提高敏感性和特異性，以及用於資料解釋的複雜的生物資訊工具。研究表明，用於即時監測的照護現場設備的開發、與人工智慧的整合進行預測分析以及擴展到癌症以外的其他疾病正在推動基於 EV 的液態切片在個性化醫療和診斷領域的使用。 。

主要市場統計
基準年[2023] 40966萬美元
預測年份 [2024] 473.12 百萬美元
預測年份 [2030] 11.508 億美元
複合年成長率（%） 15.89%

區域洞察

美國，特別是美國，由於對醫療保健研發的大量投資以及 FDA主導的強大法規結構，先進診斷解決方案（包括基於 EV 的液態切片）的採用率很高。這種環境培育了競爭格局，許多生技公司和新興企業在電動車研究和診斷方面處於領先地位。在醫療成本上升、患者意識提高和癌症盛行率上升的推動下，以中國和日本等國家主導的亞太地區基於 EV 的液態切片行業正在經歷顯著成長。該地區在政府優惠政策的支持下，專注於基於電動車的創新診斷設備的使用、生產和開發。然而，由於各國地理和經濟差異很大，該地區的市場有些分散。歐洲、中東和非洲地區擁有成熟市場和新興市場的均衡組合，其中西歐在採用基於 EV 的液態切片技術方面處於領先地位，並得到強大的醫療保健系統和對非侵入性診斷的高度認知的支持。隨著公共和私人投資的湧入，加強醫療基礎設施和服務，中東和非洲市場逐漸恢復步伐。

FPNV定位矩陣

FPNV 定位矩陣對於評估基於 EV 的液態切片市場供應商的市場定位至關重要。此矩陣提供了對供應商的全面評估，並檢驗了與業務策略和產品滿意度相關的關鍵指標。這種詳細的評估使用戶能夠根據自己的要求做出明智的決定。根據評估結果，供應商被分為代表其成功程度的四個像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市場佔有率分析

市場佔有率分析是一種綜合工具，可以對基於電動車的液態切片市場中供應商的現狀進行深入而詳細的評估。透過仔細比較和分析供應商的貢獻，您可以更深入地了解每個供應商的績效以及他們在爭奪市場佔有率時面臨的挑戰。這些貢獻包括整體收益、客戶群和其他重要指標。此外，該分析還提供了對該行業競爭性質的寶貴見解，包括在研究基準年期間觀察到的累積、分散主導地位和合併特徵等因素。有了這些詳細資訊，供應商可以做出更明智的決策並製定有效的策略，以在市場競爭中保持領先地位。

策略分析與建議

策略分析對於尋求在全球市場站穩腳跟的組織至關重要。對基於 EV 的液態切片市場當前地位的全面評估使公司能夠做出符合其長期願望的明智決策。此關鍵評估涉及對組織的資源、能力和整體績效進行徹底分析，以確定核心優勢和需要改進的領域。

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 癌症盛行率和早期療育的必要性
      • 對非侵入性診斷程序的偏好日益增加
    • 抑制因素
      • 基於EV的液態切片技術高成本
    • 機會
      • 基於 EV 的液態切片程序的進展
      • 政府對液態生物檢體的有利核准
    • 任務
      • 進行基於 EV 的液態切片時的技術問題
  • 市場區隔分析
    • 類型：檢測試劑套件的興起作為臨床診斷的基本標準化方法
    • 最終用戶：學術研究實驗室採用基於 EV 的液態切片進行藥物開發和個人化醫療
  • 市場擾動分析
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 價格分析
  • 技術分析
  • 專利分析
  • 貿易分析
  • 法規結構分析

第6章基於電動車的液態切片市場：按類型

  • 檢測套件
  • 裝置
  • 服務

第7章基於 EV 的液態切片市場：按應用分類

  • 早期癌症篩檢
  • 復發監測
  • 治療方法選擇
  • 治療監測

第8章基於電動車的液態切片市場：按最終用戶分類

  • 學術研究所
  • 臨床實驗室
  • 製藥和生物技術公司

第9章：美洲基於電動車的液態切片市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太地區基於電動車的液態切片市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲、中東和非洲基於EV的液態切片市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • Quest Diagnostics 完成對 Haystack Oncology 的收購，將敏感的 MRD液態生物檢體技術添加到癌症診斷產品組合中
    • Agena Bioscience 和 nRichDX 宣佈建立商業合作夥伴關係，共同開發液態生物檢體檢體提取和檢測解決方案
    • Mercy Bioanalytics 在 A 輪資金籌措中籌集了 4,100 萬美元，用於開發用於早期癌症檢測的新 Mercy Halo液態生物檢體平台
  • 戰略分析和建議

第13章競爭產品組合

  • 主要企業簡介
  • 主要產品系列
Product Code: MRR-2E76C3E47F69

[183 Pages Report] The EV-Based Liquid Biopsy Market size was estimated at USD 409.66 million in 2023 and expected to reach USD 473.12 million in 2024, at a CAGR 15.89% to reach USD 1,150.80 million by 2030.

EV-based liquid biopsy, encompassing the extraction and analysis of extracellular vesicles (EVs) from bodily fluids, represents a pioneering frontier in non-invasive cancer diagnostics and monitoring. EVs, which are lipid-bound particles released from cells, carry a wealth of molecular information, such as DNA, RNA, and proteins, reflective of the health status of their cells of origin. The major factors propelling the use of EV-based liquid biopsies include their non-invasive nature, the potential for early cancer detection, the capability to monitor disease progression and treatment response, and the ability to provide insights into tumor heterogeneity. Nevertheless, this nascent technology faces challenges such as the need for standardized methods for EV isolation and analysis, sensitivity in detecting low-abundance EVs, and the interpretive complexity of the data obtained. Addressing these restraints requires rigorous research to establish uniform protocols, advances in analytical technologies to enhance sensitivity and specificity, and sophisticated bioinformatics tools for data interpretation. The development of point-of-care devices for real-time monitoring, integration with artificial intelligence for predictive analytics, and expansion into other diseases beyond cancer illustrate EV-based liquid biopsy's profound impact on personalized medicine and diagnostic landscapes.

KEY MARKET STATISTICS
Base Year [2023] USD 409.66 million
Estimated Year [2024] USD 473.12 million
Forecast Year [2030] USD 1,150.80 million
CAGR (%) 15.89%

Regional Insights

In the Americas, particularly the United States, there's a high adoption rate of advanced diagnostic solutions, including EV-based liquid biopsies, driven by substantial investments in healthcare R&D and a robust regulatory framework spearheaded by the FDA. This environment fosters a competitive market landscape, with numerous biotech firms and startups pioneering in EV research and diagnostics. The APAC region, led by countries such as China and Japan, is witnessing major growth in the EV-based liquid biopsy sector, attributed to increasing healthcare expenditure, rising patient awareness, and escalating prevalence of cancer. The region's focus is on the use, production, and development of innovative EV-based diagnostics supported by favorable government policies. However, the market here is somewhat fragmented owing to the vast geographical and economic diversities between countries. The EMEA region demonstrates a balanced mix of mature and emerging markets, with Western Europe at the forefront of adopting EV-based liquid biopsy techniques, backed by strong healthcare systems and high awareness about non-invasive diagnostic methods. The Middle Eastern and African markets are gradually picking up pace, with investments flowing in from public and private sectors to enhance healthcare infrastructure and services.

Market Insights

  • Market Dynamics

The market dynamics represent an ever-changing landscape of the EV-Based Liquid Biopsy Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

    • Market Drivers
      • Prevalence of cancer and need for early intervention
      • Increasing preference for non-invasive diagnostic procedures
    • Market Restraints
      • High cost of EV-based liquid biopsy technologies
    • Market Opportunities
      • Advancements in EV-based liquid biopsy procedures
      • Favorable government approvals for liquid biopsy
    • Market Challenges
      • Technical complications of performing EV-based liquid biopsy
  • Market Segmentation Analysis
    • Type: Rise of assay kits as a standardized approach crucial for clinical diagnostics
    • End User: Adoption of EV-based liquid biopsy in academic and research laboratories for drug development and personalized medicine
  • Market Disruption Analysis
  • Porter's Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the EV-Based Liquid Biopsy Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the EV-Based Liquid Biopsy Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Quest Diagnostics Completes Acquisition of Haystack Oncology, Adding Sensitive MRD Liquid Biopsy Technology to Cancer Diagnostics Portfolio

Quest Diagnostics announces the successful completion of its acquisition of Haystack Oncology. This strategic move enriches Quest's portfolio with Haystack Oncology's minimal-residual disease (MRD) testing technology. Leveraging circulating tumor DNA (ctDNA), this advanced MRD testing technology significantly enhances the early detection capabilities for residual or recurring cancers, offering a transformative approach to guiding therapy choices. Quest Diagnostics plans to integrate this cutting-edge technology into developing novel blood-based laboratory services tailored for solid tumor cancers, marking a significant advancement in cancer diagnosis and treatment. [Published On: 2023-06-21]

Agena Bioscience and nRichDX Announce a Commercial Partnership to Create Solutions for the Extraction and Detection of Liquid Biopsy Analytes

Agena Bioscience has solidified its partnership with nRichDX, transitioning from a technical collaboration to a commercial alliance to promote its products within the research community. This partnership heralds significant advancements by coupling Agena's MassARRAY technology with nRichDX's Revolution Sample Prep System, a combination poised to redefine the landscape of liquid biopsy applications. The Revolution Sample Prep System stands out by consistently achieving higher yield extraction of these elusive variant transcripts from bodily fluids, elevating the MassARRAY platform's sensitivity threshold for detecting rare genetic markers in cancer. [Published On: 2023-04-14]

Mercy BioAnalytics Raises USD 41 Million in Series A Financing to Advance Novel Mercy Halo Liquid Biopsy Platform for Early Cancer Detection

Mercy BioAnalytics, Inc., an innovator in cancer detection through extracellular vesicle-based liquid biopsies, announced the successful closure of a notable USD 41 million in Series A funding. This achievement was led by Novalis LifeSciences and received robust support from a prestigious assembly of investors, including Sozo Ventures, Hatteras Venture Partners, iSelect Fund, American Cancer Society BrightEdge, and Broadway Angels. The investment aims to further the development of Mercy BioAnalytics' Mercy Halo platform, which stands out for its exceptional clinical sensitivity and specificity. [Published On: 2023-04-03]

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the EV-Based Liquid Biopsy Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the EV-Based Liquid Biopsy Market, highlighting leading vendors and their innovative profiles. These include Abcam PLC, Agena Bioscience, Agilent Technologies, Inc., ALS Automated Lab Solutions GmbH, ANGLE PLC, Bio-Rad Laboratories, Inc, Bio-Techne Corporation, BioFluidica, Biological Dynamics, Bristol-Myers Squibb, C.H. Boehringer Sohn AG & Co. KG, Clinomics Europe Ltd., Corning Incorporated, ExosomeDx, Horiba Ltd., Illumina, Inc., Lonza Group Ltd., Malvern Panalytical Ltd., Mercy BioAnalytics, Inc., MoBiTec GmbH by BIOZOL Diagnostica Vertrieb GmbH, Mursla Bio, Nanostics Inc., PerkinElmer, Inc., Qiagen N.V., Quest Diagnostics, System Biosciences, LLC, and Thermo Fisher Scientific, Inc..

Market Segmentation & Coverage

This research report categorizes the EV-Based Liquid Biopsy Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • Assay Kits
    • Instruments
    • Services
  • Application
    • Early Cancer Screening
    • Recurrence Monitoring
    • Therapy Selection
    • Treatment Monitoring
  • End User
    • Academic & Research Institutes
    • Clinical Laboratories
    • Pharmaceutical & Biotechnology Companies
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Prevalence of cancer and need for early intervention
      • 5.1.1.2. Increasing preference for non-invasive diagnostic procedures
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of EV-based liquid biopsy technologies
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancements in EV-based liquid biopsy procedures
      • 5.1.3.2. Favorable government approvals for liquid biopsy
    • 5.1.4. Challenges
      • 5.1.4.1. Technical complications of performing EV-based liquid biopsy
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Rise of assay kits as a standardized approach crucial for clinical diagnostics
    • 5.2.2. End User: Adoption of EV-based liquid biopsy in academic and research laboratories for drug development and personalized medicine
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. EV-Based Liquid Biopsy Market, by Type

  • 6.1. Introduction
  • 6.2. Assay Kits
  • 6.3. Instruments
  • 6.4. Services

7. EV-Based Liquid Biopsy Market, by Application

  • 7.1. Introduction
  • 7.2. Early Cancer Screening
  • 7.3. Recurrence Monitoring
  • 7.4. Therapy Selection
  • 7.5. Treatment Monitoring

8. EV-Based Liquid Biopsy Market, by End User

  • 8.1. Introduction
  • 8.2. Academic & Research Institutes
  • 8.3. Clinical Laboratories
  • 8.4. Pharmaceutical & Biotechnology Companies

9. Americas EV-Based Liquid Biopsy Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific EV-Based Liquid Biopsy Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa EV-Based Liquid Biopsy Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Quest Diagnostics Completes Acquisition of Haystack Oncology, Adding Sensitive MRD Liquid Biopsy Technology to Cancer Diagnostics Portfolio
    • 12.3.2. Agena Bioscience and nRichDX Announce a Commercial Partnership to Create Solutions for the Extraction and Detection of Liquid Biopsy Analytes
    • 12.3.3. Mercy BioAnalytics Raises USD 41 Million in Series A Financing to Advance Novel Mercy Halo Liquid Biopsy Platform for Early Cancer Detection
  • 12.4. Strategy Analysis & Recommendation

13. Competitive Portfolio

  • 13.1. Key Company Profiles
  • 13.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. EV-BASED LIQUID BIOPSY MARKET RESEARCH PROCESS
  • FIGURE 2. EV-BASED LIQUID BIOPSY MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. EV-BASED LIQUID BIOPSY MARKET DYNAMICS
  • FIGURE 7. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS EV-BASED LIQUID BIOPSY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS EV-BASED LIQUID BIOPSY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES EV-BASED LIQUID BIOPSY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES EV-BASED LIQUID BIOPSY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC EV-BASED LIQUID BIOPSY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC EV-BASED LIQUID BIOPSY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA EV-BASED LIQUID BIOPSY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA EV-BASED LIQUID BIOPSY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. EV-BASED LIQUID BIOPSY MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 22. EV-BASED LIQUID BIOPSY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. EV-BASED LIQUID BIOPSY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY ASSAY KITS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY ASSAY KITS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY INSTRUMENTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY SERVICES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY SERVICES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY EARLY CANCER SCREENING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY EARLY CANCER SCREENING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY RECURRENCE MONITORING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY RECURRENCE MONITORING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY THERAPY SELECTION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY THERAPY SELECTION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY TREATMENT MONITORING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY TREATMENT MONITORING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY CLINICAL LABORATORIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY CLINICAL LABORATORIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. AMERICAS EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 34. AMERICAS EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 35. AMERICAS EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 36. AMERICAS EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 37. AMERICAS EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 38. AMERICAS EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 39. AMERICAS EV-BASED LIQUID BIOPSY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 40. AMERICAS EV-BASED LIQUID BIOPSY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 41. ARGENTINA EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 42. ARGENTINA EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 43. ARGENTINA EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 44. ARGENTINA EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 45. ARGENTINA EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 46. ARGENTINA EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 47. BRAZIL EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 48. BRAZIL EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 49. BRAZIL EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 50. BRAZIL EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 51. BRAZIL EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 52. BRAZIL EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 53. CANADA EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 54. CANADA EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 55. CANADA EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 56. CANADA EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 57. CANADA EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 58. CANADA EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 59. MEXICO EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 60. MEXICO EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 61. MEXICO EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 62. MEXICO EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 63. MEXICO EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 64. MEXICO EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 65. UNITED STATES EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 66. UNITED STATES EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 67. UNITED STATES EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 68. UNITED STATES EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 69. UNITED STATES EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 70. UNITED STATES EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 71. UNITED STATES EV-BASED LIQUID BIOPSY MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 72. UNITED STATES EV-BASED LIQUID BIOPSY MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 73. ASIA-PACIFIC EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 74. ASIA-PACIFIC EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 75. ASIA-PACIFIC EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 76. ASIA-PACIFIC EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 77. ASIA-PACIFIC EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 78. ASIA-PACIFIC EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 79. ASIA-PACIFIC EV-BASED LIQUID BIOPSY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 80. ASIA-PACIFIC EV-BASED LIQUID BIOPSY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 81. AUSTRALIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 82. AUSTRALIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 83. AUSTRALIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 84. AUSTRALIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 85. AUSTRALIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 86. AUSTRALIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 87. CHINA EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 88. CHINA EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 89. CHINA EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 90. CHINA EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 91. CHINA EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 92. CHINA EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 93. INDIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 94. INDIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 95. INDIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 96. INDIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 97. INDIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 98. INDIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 99. INDONESIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 100. INDONESIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 101. INDONESIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 102. INDONESIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 103. INDONESIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 104. INDONESIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 105. JAPAN EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 106. JAPAN EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 107. JAPAN EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 108. JAPAN EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 109. JAPAN EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 110. JAPAN EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 111. MALAYSIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 112. MALAYSIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 113. MALAYSIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 114. MALAYSIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 115. MALAYSIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 116. MALAYSIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 117. PHILIPPINES EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 118. PHILIPPINES EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 119. PHILIPPINES EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 120. PHILIPPINES EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 121. PHILIPPINES EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 122. PHILIPPINES EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 123. SINGAPORE EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 124. SINGAPORE EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 125. SINGAPORE EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 126. SINGAPORE EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 127. SINGAPORE EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 128. SINGAPORE EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 129. SOUTH KOREA EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 130. SOUTH KOREA EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 131. SOUTH KOREA EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 132. SOUTH KOREA EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 133. SOUTH KOREA EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 134. SOUTH KOREA EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 135. TAIWAN EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 136. TAIWAN EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 137. TAIWAN EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 138. TAIWAN EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 139. TAIWAN EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 140. TAIWAN EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 141. THAILAND EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 142. THAILAND EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 143. THAILAND EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 144. THAILAND EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 145. THAILAND EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 146. THAILAND EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 147. VIETNAM EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 148. VIETNAM EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 149. VIETNAM EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 150. VIETNAM EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 151. VIETNAM EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 152. VIETNAM EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 156. EUROPE, MIDDLE EAST & AFRICA EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 157. EUROPE, MIDDLE EAST & AFRICA EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 158. EUROPE, MIDDLE EAST & AFRICA EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 159. EUROPE, MIDDLE EAST & AFRICA EV-BASED LIQUID BIOPSY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 160. EUROPE, MIDDLE EAST & AFRICA EV-BASED LIQUID BIOPSY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 161. DENMARK EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 162. DENMARK EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 163. DENMARK EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 164. DENMARK EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 165. DENMARK EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 166. DENMARK EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 167. EGYPT EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 168. EGYPT EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 169. EGYPT EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 170. EGYPT EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 171. EGYPT EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 172. EGYPT EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 173. FINLAND EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 174. FINLAND EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 175. FINLAND EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 176. FINLAND EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 177. FINLAND EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 178. FINLAND EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 179. FRANCE EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 180. FRANCE EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 181. FRANCE EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 182. FRANCE EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 183. FRANCE EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 184. FRANCE EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 185. GERMANY EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 186. GERMANY EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 187. GERMANY EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 188. GERMANY EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 189. GERMANY EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 190. GERMANY EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 191. ISRAEL EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 192. ISRAEL EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 193. ISRAEL EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 194. ISRAEL EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 195. ISRAEL EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 196. ISRAEL EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 197. ITALY EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 198. ITALY EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 199. ITALY EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 200. ITALY EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 201. ITALY EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 202. ITALY EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 203. NETHERLANDS EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 204. NETHERLANDS EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 205. NETHERLANDS EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 206. NETHERLANDS EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 207. NETHERLANDS EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 208. NETHERLANDS EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 209. NIGERIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 210. NIGERIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 211. NIGERIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 212. NIGERIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 213. NIGERIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 214. NIGERIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 215. NORWAY EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 216. NORWAY EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 217. NORWAY EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 218. NORWAY EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 219. NORWAY EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 220. NORWAY EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 221. POLAND EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 222. POLAND EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 223. POLAND EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 224. POLAND EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 225. POLAND EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 226. POLAND EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 227. QATAR EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 228. QATAR EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 229. QATAR EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 230. QATAR EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 231. QATAR EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 232. QATAR EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 233. RUSSIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 234. RUSSIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 235. RUSSIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 236. RUSSIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 237. RUSSIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 238. RUSSIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 239. SAUDI ARABIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 240. SAUDI ARABIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 241. SAUDI ARABIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 242. SAUDI ARABIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 243. SAUDI ARABIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 244. SAUDI ARABIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 245. SOUTH AFRICA EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 246. SOUTH AFRICA EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 247. SOUTH AFRICA EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 248. SOUTH AFRICA EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 249. SOUTH AFRICA EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 250. SOUTH AFRICA EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 251. SPAIN EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 252. SPAIN EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 253. SPAIN EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 254. SPAIN EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 255. SPAIN EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 256. SPAIN EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 257. SWEDEN EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 258. SWEDEN EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 259. SWEDEN EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 260. SWEDEN EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 261. SWEDEN EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 262. SWEDEN EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 263. SWITZERLAND EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 264. SWITZERLAND EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 265. SWITZERLAND EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 266. SWITZERLAND EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 267. SWITZERLAND EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 268. SWITZERLAND EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 269. TURKEY EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 270. TURKEY EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 271. TURKEY EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 272. TURKEY EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 273. TURKEY EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 274. TURKEY EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 275. UNITED ARAB EMIRATES EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 276. UNITED ARAB EMIRATES EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 277. UNITED ARAB EMIRATES EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 278. UNITED ARAB EMIRATES EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 279. UNITED ARAB EMIRATES EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 280. UNITED ARAB EMIRATES EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 281. UNITED KINGDOM EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 282. UNITED KINGDOM EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 283. UNITED KINGDOM EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 284. UNITED KINGDOM EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 285. UNITED KINGDOM EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 286. UNITED KINGDOM EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 287. EV-BASED LIQUID BIOPSY MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 288. EV-BASED LIQUID BIOPSY MARKET, FPNV POSITIONING MATRIX, 2023